|
|
|
Volumn 23, Issue 2, 2011, Pages 152-153
|
|
Tamoxifen-SSRIs interaction: Clinical manifestations of inhibition and lack of inhibition of CYP2D6
a
b,c
|
|
Author keywords
Breast cancer; Metabolism; Tamoxifen
|
|
Indexed keywords
AFIMOXIFENE;
CITALOPRAM;
CYTOCHROME P450 2D6;
ENDOXIFEN;
FLUOXETINE;
HORMONE RECEPTOR;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
TAMOXIFEN;
ANTINEOPLASTIC AGENT;
ADULT;
CASE REPORT;
CLINICAL FEATURE;
DEPRESSION;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ENZYME INHIBITION;
FEMALE;
HOT FLUSH;
HUMAN;
IN VITRO STUDY;
INTRADUCTAL CARCINOMA;
LETTER;
MAJOR DEPRESSION;
MOOD CHANGE;
PRIORITY JOURNAL;
RELAPSE;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG INTERACTION;
MIDDLE AGED;
PAGET NIPPLE DISEASE;
PSYCHOLOGICAL ASPECT;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL;
CITALOPRAM;
CYTOCHROME P-450 CYP2D6;
DEPRESSIVE DISORDER, MAJOR;
DRUG INTERACTIONS;
FEMALE;
HOT FLASHES;
HUMANS;
MIDDLE AGED;
PAROXETINE;
SEROTONIN UPTAKE INHIBITORS;
TAMOXIFEN;
|
|
EID: 80052092894
PISSN: 10401237
EISSN: 15473325
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (2)
|
|
References (3)
|
